NAS:ALPN (USA) Also Trade In: Germany

Alpine Immune Sciences Inc $ 7.82 -0.85 (-9.8%)

Volume:
74,157
Avg Vol (1m):
80,598
Market Cap $:
186.01 Mil
Enterprise Value $:
117.73 Mil
P/E (TTM):
0.00
P/B:
8.96
Warning! GuruFocus has detected 2 Severe warning signs with ALPN. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 10Y (-%)
PE Ratio P/S Ratio P/B Ratio Price-FCF Ratio Market Cap
Current and historical daily P/E ratio for Alpine Immune Sciences Inc () from 2015 to Sep 21 2020. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Alpine Immune Sciences stock (ALPN) PE ratio as of Sep 21 2020 is 0. More Details

Alpine Immune Sciences PE Ratio (TTM) Chart

EMBED

Alpine Immune Sciences PE Ratio (TTM) Historical Data

Total 1294
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Alpine Immune Sciences PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2020-09-220.0 2020-07-210.0
2020-09-210.0 2020-07-200.0
2020-09-180.0 2020-07-170.0
2020-09-170.0 2020-07-160.0
2020-09-160.0 2020-07-150.0
2020-09-150.0 2020-07-140.0
2020-09-140.0 2020-07-130.0
2020-09-110.0 2020-07-100.0
2020-09-100.0 2020-07-090.0
2020-09-090.0 2020-07-080.0
2020-09-080.0 2020-07-070.0
2020-09-070.0 2020-07-060.0
2020-09-040.0 2020-07-030.0
2020-09-030.0 2020-07-020.0
2020-09-020.0 2020-07-010.0
2020-09-010.0 2020-06-300.0
2020-08-310.0 2020-06-290.0
2020-08-280.0 2020-06-260.0
2020-08-270.0 2020-06-250.0
2020-08-260.0 2020-06-240.0
2020-08-250.0 2020-06-230.0
2020-08-240.0 2020-06-220.0
2020-08-210.0 2020-06-190.0
2020-08-200.0 2020-06-180.0
2020-08-190.0 2020-06-170.0
2020-08-180.0 2020-06-160.0
2020-08-170.0 2020-06-150.0
2020-08-140.0 2020-06-120.0
2020-08-130.0 2020-06-110.0
2020-08-120.0 2020-06-100.0
2020-08-110.0 2020-06-090.0
2020-08-100.0 2020-06-080.0
2020-08-070.0 2020-06-050.0
2020-08-060.0 2020-06-040.0
2020-08-050.0 2020-06-030.0
2020-08-040.0 2020-06-020.0
2020-08-030.0 2020-06-010.0
2020-07-310.0 2020-05-290.0
2020-07-300.0 2020-05-280.0
2020-07-290.0 2020-05-270.0
2020-07-280.0 2020-05-260.0
2020-07-270.0 2020-05-250.0
2020-07-240.0 2020-05-220.0
2020-07-230.0 2020-05-210.0
2020-07-220.0 2020-05-200.0

Alpine Immune Sciences PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Industry Healthcare » Biotechnology » NAICS : 325412 NAICS : 2834
Traded in other countries 34LA.Germany ALPN.USA
Address 188 East Blaine Street, Suite 200, Seattle, WA, USA, 98102
Alpine Immune Sciences Inc is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing modern, protein-based immunotherapies targeting the immune synapse to treat cancer, inflammation, and other diseases. The company's proprietary scientific platform uses a process known as directed evolution to create therapeutics capable of modulating human immune system proteins. Its product pipeline includes ALPN-101 and ALPN-202.